Overview

Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide

Status:
Completed
Trial end date:
2018-09-30
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, 3-arm, fixed sequence, study to evaluate vadadustat as a perpetrator of drug-drug interactions (DDIs) with digoxin, adefovir and furosemide in healthy male and female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Akebia Therapeutics
Treatments:
Adefovir
Adefovir dipivoxil
Digoxin
Furosemide